Advanced glycation end-products (AGEs) are irreversible protein modifications that are strongly associated with aging and disease. Recently, the Parkinsonism-associated protein DJ-1 has been reported to exhibit deglycase activity that erases early glycation intermediates and stable AGEs from proteins. In this work, we use mass spectrometry and western blot to demonstrate that DJ-1 is not a deglycase and cannot remove AGEs from protein or peptide substrates. Instead, our studies revealed that DJ-1 antagonizes glycation through glyoxalase activity that detoxifies the potent glycating agent methylglyoxal (MGO) to lactate. We further show that attenuated glycation in the presence of DJ-1 can be attributed solely to its ability to decrease the a...
Methylglyoxal (MG) is a potent protein glycating agent. Glycation is directed to guanidino groups of...
Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide, caused by th...
Methylglyoxal (MG) is quantitatively the most important precursor to advanced glycation end-products...
International audienceGlycation is an inevitable nonenzymatic covalent reaction between proteins and...
The recently reported deglycating activity of DJ-1 reconciles several features previously described ...
Human DJ-1 is a cytoprotective protein whose absence causes Parkinson\u27s disease and is also assoc...
The protein PARK7 (also known as DJ-1) has been implicated in several diseases, with the most notabl...
Methylglyoxal (MG) is a reactive metabolite that forms adducts on cysteine, lysine and arginine resi...
The posttranslational modification of macromolecules caused by highly reactive and toxic α-dicarbony...
Glycation of α-synuclein (αSyn), as occurs with aging, has been linked to the progression of Parkins...
Parkinson's disease is associated with mitochondrial decline in dopaminergic neurons of the substant...
Parkinson's disease is associated with mitochondrial decline in dopaminergic neurons of the substant...
Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide, caused by th...
Parkinson’s disease is associated with mitochondrial decline in dopaminergic neurons of the substant...
Alzheimer's disease (AD) is the most common dementing disorder of late life. Although there might be...
Methylglyoxal (MG) is a potent protein glycating agent. Glycation is directed to guanidino groups of...
Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide, caused by th...
Methylglyoxal (MG) is quantitatively the most important precursor to advanced glycation end-products...
International audienceGlycation is an inevitable nonenzymatic covalent reaction between proteins and...
The recently reported deglycating activity of DJ-1 reconciles several features previously described ...
Human DJ-1 is a cytoprotective protein whose absence causes Parkinson\u27s disease and is also assoc...
The protein PARK7 (also known as DJ-1) has been implicated in several diseases, with the most notabl...
Methylglyoxal (MG) is a reactive metabolite that forms adducts on cysteine, lysine and arginine resi...
The posttranslational modification of macromolecules caused by highly reactive and toxic α-dicarbony...
Glycation of α-synuclein (αSyn), as occurs with aging, has been linked to the progression of Parkins...
Parkinson's disease is associated with mitochondrial decline in dopaminergic neurons of the substant...
Parkinson's disease is associated with mitochondrial decline in dopaminergic neurons of the substant...
Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide, caused by th...
Parkinson’s disease is associated with mitochondrial decline in dopaminergic neurons of the substant...
Alzheimer's disease (AD) is the most common dementing disorder of late life. Although there might be...
Methylglyoxal (MG) is a potent protein glycating agent. Glycation is directed to guanidino groups of...
Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide, caused by th...
Methylglyoxal (MG) is quantitatively the most important precursor to advanced glycation end-products...